119 related articles for article (PubMed ID: 6205336)
1. [Calcitonin in bone-metastasizing breast carcinoma. Results of a pilot study].
Beaufort F; Gölles M
Onkologie; 1984 Jun; 7(3):137-40. PubMed ID: 6205336
[TBL] [Abstract][Full Text] [Related]
2. Management of breast cancer with bone metastases.
Clavel M
Bone; 1991; 12 Suppl 1():S11-2. PubMed ID: 1720011
[No Abstract] [Full Text] [Related]
3. [The analgesic effect of calcitonin on breast cancer patients with bone metastases].
Kimura M; Abe R
Gan No Rinsho; 1987 Jul; 33(8):921-7. PubMed ID: 3613114
[TBL] [Abstract][Full Text] [Related]
4. [Medroxyprogesterone acetate for treatment of advanced breast cancers].
Mitsuyama S; Anan K
Nihon Rinsho; 2000 Apr; 58 Suppl():317-21. PubMed ID: 11026012
[No Abstract] [Full Text] [Related]
5. [Remarkable pain relief in the treatment with high-dose medroxyprogesterone acetate in advanced prostatic carcinoma].
Sasagawa I; Satomi S; Katayama T
Gan No Rinsho; 1989 May; 35(6):767-71. PubMed ID: 2470932
[TBL] [Abstract][Full Text] [Related]
6. Calcitonin in the treatment of intractable pain from advanced malignancy.
Allan E
Pharmatherapeutica; 1983; 3(7):482-6. PubMed ID: 6669591
[TBL] [Abstract][Full Text] [Related]
7. [Effect of porcine calcitonin on pain caused by cancer-induced bone destruction].
Egawa J; Kawada Y; Abe M; Miki H; Fujinuma A; Utsunomia Y; Kawano H; Kawaguchi H; Kuroiwa S; Saito A
Gan No Rinsho; 1984 Mar; 30(3):251-8. PubMed ID: 6716657
[TBL] [Abstract][Full Text] [Related]
8. [Radiotherapy of metastatic bone tumor with a synthetic calcitonin derivative (Elcatonin) with irradiation].
Aoki Y; Akanuma T; Karasawa K; Minami M; Sakata K; Iio M
Gan To Kagaku Ryoho; 1985 Feb; 12(2):289-97. PubMed ID: 2982331
[TBL] [Abstract][Full Text] [Related]
9. [Advanced breast cancer with multiple bone metastases successfully treated with combined chemoendocrine-therapy of CEF (cyclophosphamide, epirubicin, 5-fluorouracil) and 5'-DFUR (5'-deoxy-5-fluorouridine) + MPA (medroxyprogesterone acetate)--a case report].
Fukuda Y; Hirao S; Koyama I; Takatori H; Terakura M; Mayumi K; Tsukazaki Y; Kinoshita H
Gan To Kagaku Ryoho; 2001 Feb; 28(2):217-20. PubMed ID: 11242649
[TBL] [Abstract][Full Text] [Related]
10. Sequential hormone-chemotherapy (MAP at high doses and CMF) in metastatic breast cancer. Preliminary results.
Pannuti F; Di Marco AR; Rossi AP; Rocchetta G; Rubino I; Giovannini M; Fruet F
Panminerva Med; 1981; 23(2):93-6. PubMed ID: 6459558
[No Abstract] [Full Text] [Related]
11. Issues concerning the role of chemotherapy and hormonal therapy of bone metastases from breast carcinoma.
Harvey HA
Cancer; 1997 Oct; 80(8 Suppl):1646-51. PubMed ID: 9362431
[TBL] [Abstract][Full Text] [Related]
12. [Systemic therapy, pain relief and quality of life of breast cancer patients with bone metastasis].
Sonoo H; Shimozuma K; Kurebayashi J; Ohta K; Kiyono T
Gan To Kagaku Ryoho; 1995 Apr; 22 Suppl 1():10-5. PubMed ID: 7747985
[TBL] [Abstract][Full Text] [Related]
13. [Criteria for evaluating the efficacy of treatment of breast cancer metastases to the bones].
Lichinitser MR; Vyshinskaia GV; Gritsaĭ AA; Kondrat'eva AP; Luk'ianchenko AB
Med Radiol (Mosk); 1986 Feb; 31(2):28-31. PubMed ID: 3951344
[TBL] [Abstract][Full Text] [Related]
14. [Does Calcitonin have an analgetic effect on bone pain related to metastatic cancer?].
Engelhardt M
Dtsch Med Wochenschr; 2012 Dec; 137(50):2629. PubMed ID: 23225184
[No Abstract] [Full Text] [Related]
15. [The efficacy of combination chemotherapy of 5'-deoxy-5-fluorouridine (5'-DFUR), cyclophosphamide (CPA) and medroxyprogesterone acetate (MPA) for bone metastasis in breast cancer patients].
Iba T; Kidokoro A; Fukunaga M; Sugiyama K; Aihara N; Suda M
Gan To Kagaku Ryoho; 2001 Jul; 28(7):973-7. PubMed ID: 11478147
[TBL] [Abstract][Full Text] [Related]
16. Multidrug-resistant recurrent breast cancer which responded to medroxyprogesterone acetate showing a remarkable improvement in the quality of life: report of a case and the role of team medical care.
Kurihara T; Higashi Y; Suemasu K; Tabei T; Ishiguro S; Iino Y; Morishita Y; Takeda F
Surg Today; 1998; 28(9):979-84. PubMed ID: 9744415
[TBL] [Abstract][Full Text] [Related]
17. [Use of adriamycin in the treatment of metastatic breast cancer].
Dymarskiĭ LIu; Sanchakova AV; Aleksandrova GI; Trishkina EA
Vopr Onkol; 1984; 30(6):67-73. PubMed ID: 6547554
[TBL] [Abstract][Full Text] [Related]
18. [Clinical evaluation of cyclophosphamide, methotrexate and 5-fluorouracil (CMF) on advanced and recurrent breast cancer. Clinical study group of CMF for breast cancer in Japan].
Nomura Y; Tominaga T; Adachi I; Koyama H; Fukami A
Gan To Kagaku Ryoho; 1994 Sep; 21(12):1949-56. PubMed ID: 8085846
[TBL] [Abstract][Full Text] [Related]
19. Treatment of advanced breast cancer: How much chemotherapy is enough?
DiPaola RS; Kaufman A; Mikhail MM
Semin Oncol; 1996 Jun; 23(3):xv-xxii; discussion xxii-xxiv. PubMed ID: 8658211
[No Abstract] [Full Text] [Related]
20. [Two cases of advanced breast cancer responding to oral chemoendocrine therapy with 5'-deoxy-5-fluorouridine, medroxyprogesterone acetate and cyclophosphamide (DMpC)].
Kihara M; Kontani K; Yamauchi A; Yokomise H
Gan To Kagaku Ryoho; 2005 May; 32(5):683-6. PubMed ID: 15918573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
